Bruce Montgomery Overview

  • Investor Type
  • Angel
  • Investments
  • 3
  • Exits
  • 2
Exits

Bruce Montgomery General Information

Description

Dr. Bruce Montgomery serves as Chief Executive Officer and Board Member at Avalyn. Prior to Avalyn, Dr. Montgomery was a Co-Founder and served as the Chief Executive Officer & Board Member at Cardeas Pharma. He also served as Board Member at Athira Pharma. He also serves as an Investment Committee Member at The W Fund. He serves as Chief Executive Officer at Life Sciences Discovery Fund. He previously held the position of Senior Vice President, Respiratory Therapeutics at Gilead Sciences, Inc. Before his work with Gilead, Dr. Montgomery was the Founder and CEO of Corus Pharma of Seattle, a drug development company focusing on infectious disease and respiratory drugs. Corus Pharma was purchased by Gilead Sciences, Inc. in August of 2006. Until October 2000, Dr. Montgomery served as Executive Vice President of Research and Development at PathoGenesis Corporation. He has extensive pharmaceutical company experience in drug development, operations and financing. He received his B.S. in Chemistry (Magna cum Laude, Outstanding Chemistry Major [Merck Award]), and M.D. (Alpha Omega Alpha Honor Medical Society) from the University of Washington, Seattle. He is a board certified internist and pulmonologist.

Contact Information

Primary Investor Type
Angel (individual)

Bruce Montgomery Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Athira Pharma 13-Oct-2017 Later Stage VC 000.00 Drug Discovery Clinical Trials - Phase 2 00000 0000000000 00
00000 24-May-2016 00000 00000 0000 Recreational Goods Generating Revenue 00000 0000000000 00
000000 000000 11-Feb-2016 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 00000 0000000000 00
To view Bruce Montgomery’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bruce Montgomery Exits (2)

Company Name Exit Date Exit Type Exit Size
Athira Pharma 18-Sep-2020 IPO 00000
00000 31-Dec-2019 0000000000: 000000
To view Bruce Montgomery’s complete exits history, request access »

Bruce Montgomery Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Bruce Montgomery Team (1)

Name Title Deals Funds Boards Office
Bruce Montgomery MD Angel Investor 0 0 0 San Diego, CA
To view Bruce Montgomery’s complete team members history, request access »

Bruce Montgomery Co-Investors (8)

Name With Exits Lead Partner Series Industry
Alzheimers Drug Discovery Foundation 1 0 Series chart Industry bar
Dolby Family Ventures 0 0 Series chart Industry bar
Kayne Anderson Capital Advisors 0 0 Series chart Industry bar
The W Fund 0 0 Series chart Industry bar
WRF Capital 0 0 Series chart Industry bar
You’re viewing 5 of 8 co-investors. Get the full list »